MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation

Eyob Feyssa, Jorge Ortiz, Kevin Grewal, Ashaur Azhar, Afshin Parsikia, Kashif Tufail, Nikroo Hashemi, Paul Brady, Victor Araya

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is used in the management of refractory ascites (RA) and variceal bleeds. Little data exist on TIPS safety, efficacy, and survival after liver transplantation (LT). METHODS.: We conducted a retrospective analysis of patients who underwent TIPS placement after LT for RA. Clinical success was defined as a reduction of portosystemic gradient (PSG) and resolution of RA. Results: Twenty-six patients underwent TIPS. The most common indication for LT was hepatitis C virus (88%). Median time from LT to TIPS was 17 months (1-89 months). Median pre-TIPS model for end-stage liver disease (MELD) score was 15 (7-33). The median pre-TIPS PSG was 18 mm Hg (7-38 mm Hg). Median change in the PSG after TIPS was 11 mm Hg (1-27 mm Hg). Fifty-eight percent (15/26) of TIPS were considered clinically successful. Median post-TIPS patient survival was 15 months (1-109 months). Cumulative 1-year post-TIPS patient survival was 50%. On multivariate analysis, pre-TIPS MELD was a significant and independent predictor of patient survival (P<0.01). The 3- and 6-month patient mortality and graft loss for patients with a pre-TIPS MELD of more than or equal to 15 were significantly higher than those with a pre-TIPS MELD score of less than 15 (P<0.01). The overall median survival for patients with a pre-TIPS MELD score of more than or equal to 15 was 3 months (1-59 months) compared with 45 months (2-109 months) for patients with pre-TIPS MELD score of less than 15. Conclusions: TIPS after LT can be clinically effective in patients with RA with a MELD score less than 15. This suggests that TIPS could be used as a means to extend posttransplant survival but should be carefully individualized in patients with a MELD score more than or equal to 15.

Original languageEnglish (US)
Pages (from-to)786-792
Number of pages7
JournalTransplantation
Volume91
Issue number7
DOIs
StatePublished - Apr 15 2011
Externally publishedYes

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
End Stage Liver Disease
Ascites
Liver Transplantation
Survival

Keywords

  • Liver transplantation
  • MELD score
  • Refractory ascites
  • Transjugular intrahepatic portosystemic shunt

ASJC Scopus subject areas

  • Transplantation

Cite this

MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. / Feyssa, Eyob; Ortiz, Jorge; Grewal, Kevin; Azhar, Ashaur; Parsikia, Afshin; Tufail, Kashif; Hashemi, Nikroo; Brady, Paul; Araya, Victor.

In: Transplantation, Vol. 91, No. 7, 15.04.2011, p. 786-792.

Research output: Contribution to journalArticle

Feyssa, Eyob ; Ortiz, Jorge ; Grewal, Kevin ; Azhar, Ashaur ; Parsikia, Afshin ; Tufail, Kashif ; Hashemi, Nikroo ; Brady, Paul ; Araya, Victor. / MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. In: Transplantation. 2011 ; Vol. 91, No. 7. pp. 786-792.
@article{aec09c2c23ff4d4fb4463393800e6b40,
title = "MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation",
abstract = "Background: Transjugular intrahepatic portosystemic shunt (TIPS) is used in the management of refractory ascites (RA) and variceal bleeds. Little data exist on TIPS safety, efficacy, and survival after liver transplantation (LT). METHODS.: We conducted a retrospective analysis of patients who underwent TIPS placement after LT for RA. Clinical success was defined as a reduction of portosystemic gradient (PSG) and resolution of RA. Results: Twenty-six patients underwent TIPS. The most common indication for LT was hepatitis C virus (88{\%}). Median time from LT to TIPS was 17 months (1-89 months). Median pre-TIPS model for end-stage liver disease (MELD) score was 15 (7-33). The median pre-TIPS PSG was 18 mm Hg (7-38 mm Hg). Median change in the PSG after TIPS was 11 mm Hg (1-27 mm Hg). Fifty-eight percent (15/26) of TIPS were considered clinically successful. Median post-TIPS patient survival was 15 months (1-109 months). Cumulative 1-year post-TIPS patient survival was 50{\%}. On multivariate analysis, pre-TIPS MELD was a significant and independent predictor of patient survival (P<0.01). The 3- and 6-month patient mortality and graft loss for patients with a pre-TIPS MELD of more than or equal to 15 were significantly higher than those with a pre-TIPS MELD score of less than 15 (P<0.01). The overall median survival for patients with a pre-TIPS MELD score of more than or equal to 15 was 3 months (1-59 months) compared with 45 months (2-109 months) for patients with pre-TIPS MELD score of less than 15. Conclusions: TIPS after LT can be clinically effective in patients with RA with a MELD score less than 15. This suggests that TIPS could be used as a means to extend posttransplant survival but should be carefully individualized in patients with a MELD score more than or equal to 15.",
keywords = "Liver transplantation, MELD score, Refractory ascites, Transjugular intrahepatic portosystemic shunt",
author = "Eyob Feyssa and Jorge Ortiz and Kevin Grewal and Ashaur Azhar and Afshin Parsikia and Kashif Tufail and Nikroo Hashemi and Paul Brady and Victor Araya",
year = "2011",
month = "4",
day = "15",
doi = "10.1097/TP.0b013e31820e014e",
language = "English (US)",
volume = "91",
pages = "786--792",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation

AU - Feyssa, Eyob

AU - Ortiz, Jorge

AU - Grewal, Kevin

AU - Azhar, Ashaur

AU - Parsikia, Afshin

AU - Tufail, Kashif

AU - Hashemi, Nikroo

AU - Brady, Paul

AU - Araya, Victor

PY - 2011/4/15

Y1 - 2011/4/15

N2 - Background: Transjugular intrahepatic portosystemic shunt (TIPS) is used in the management of refractory ascites (RA) and variceal bleeds. Little data exist on TIPS safety, efficacy, and survival after liver transplantation (LT). METHODS.: We conducted a retrospective analysis of patients who underwent TIPS placement after LT for RA. Clinical success was defined as a reduction of portosystemic gradient (PSG) and resolution of RA. Results: Twenty-six patients underwent TIPS. The most common indication for LT was hepatitis C virus (88%). Median time from LT to TIPS was 17 months (1-89 months). Median pre-TIPS model for end-stage liver disease (MELD) score was 15 (7-33). The median pre-TIPS PSG was 18 mm Hg (7-38 mm Hg). Median change in the PSG after TIPS was 11 mm Hg (1-27 mm Hg). Fifty-eight percent (15/26) of TIPS were considered clinically successful. Median post-TIPS patient survival was 15 months (1-109 months). Cumulative 1-year post-TIPS patient survival was 50%. On multivariate analysis, pre-TIPS MELD was a significant and independent predictor of patient survival (P<0.01). The 3- and 6-month patient mortality and graft loss for patients with a pre-TIPS MELD of more than or equal to 15 were significantly higher than those with a pre-TIPS MELD score of less than 15 (P<0.01). The overall median survival for patients with a pre-TIPS MELD score of more than or equal to 15 was 3 months (1-59 months) compared with 45 months (2-109 months) for patients with pre-TIPS MELD score of less than 15. Conclusions: TIPS after LT can be clinically effective in patients with RA with a MELD score less than 15. This suggests that TIPS could be used as a means to extend posttransplant survival but should be carefully individualized in patients with a MELD score more than or equal to 15.

AB - Background: Transjugular intrahepatic portosystemic shunt (TIPS) is used in the management of refractory ascites (RA) and variceal bleeds. Little data exist on TIPS safety, efficacy, and survival after liver transplantation (LT). METHODS.: We conducted a retrospective analysis of patients who underwent TIPS placement after LT for RA. Clinical success was defined as a reduction of portosystemic gradient (PSG) and resolution of RA. Results: Twenty-six patients underwent TIPS. The most common indication for LT was hepatitis C virus (88%). Median time from LT to TIPS was 17 months (1-89 months). Median pre-TIPS model for end-stage liver disease (MELD) score was 15 (7-33). The median pre-TIPS PSG was 18 mm Hg (7-38 mm Hg). Median change in the PSG after TIPS was 11 mm Hg (1-27 mm Hg). Fifty-eight percent (15/26) of TIPS were considered clinically successful. Median post-TIPS patient survival was 15 months (1-109 months). Cumulative 1-year post-TIPS patient survival was 50%. On multivariate analysis, pre-TIPS MELD was a significant and independent predictor of patient survival (P<0.01). The 3- and 6-month patient mortality and graft loss for patients with a pre-TIPS MELD of more than or equal to 15 were significantly higher than those with a pre-TIPS MELD score of less than 15 (P<0.01). The overall median survival for patients with a pre-TIPS MELD score of more than or equal to 15 was 3 months (1-59 months) compared with 45 months (2-109 months) for patients with pre-TIPS MELD score of less than 15. Conclusions: TIPS after LT can be clinically effective in patients with RA with a MELD score less than 15. This suggests that TIPS could be used as a means to extend posttransplant survival but should be carefully individualized in patients with a MELD score more than or equal to 15.

KW - Liver transplantation

KW - MELD score

KW - Refractory ascites

KW - Transjugular intrahepatic portosystemic shunt

UR - http://www.scopus.com/inward/record.url?scp=79954703725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954703725&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31820e014e

DO - 10.1097/TP.0b013e31820e014e

M3 - Article

C2 - 21304440

AN - SCOPUS:79954703725

VL - 91

SP - 786

EP - 792

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -